Report Content
Chapter 1 Methodology
1.1 Market definitions
1.2 Base estimates & working
1.2.1 North America
1.2.2 Europe
1.2.3 Asia Pacific
1.2.4 Latin America
1.2.5 MEA
1.3 Forecast parameters
1.4 Data validation
1.5 Data sources
1.5.1 Secondary
1.5.1.1 Paid sources
1.5.1.2 Unpaid sources
1.5.2 Primary
Chapter 2 Executive Summary
2.1 Blood and blood components industry 360° synopsis, 2017-2028
2.1.1 Business trends
2.1.2 Product trends
2.1.3 Application trends
2.1.4 End-use trends
2.1.5 Regional trends
Chapter 3 Blood and Blood Components Industry Insights
3.1 Industry segmentation
3.2 Industry landscape, 2017 - 2028
3.3 Industry impact forces
3.3.1 Growth drivers
3.3.1.1 Increasing volume of surgeries globally
3.3.1.2 Rising number of people from chronic conditions including cancer
3.3.1.3 Growing popularity of plasma therapy to treat various sport injuries, cosmetic as well as orthopaedic procedures
3.3.1.4 Several blood donation campaigns undertaken by various blood organizations
3.3.2 Industry pitfalls & challenges
3.3.2.1 Declining number of blood donations
3.3.2.2 Transfusion transmitted infection (TTI) related to donated blood
3.4 Growth potential analysis
3.4.1 By product
3.4.2 By application
3.4.3 By end-use
3.5 COVID-19 impact analysis
3.6 Regulatory landscape
3.6.1 U.S.
3.6.2 Europe
3.7 Industry ecosystem
3.7.1 Supply chain analysis
3.8 Porter's analysis
3.9 Competitive landscape, 2021
3.9.1 Company matrix analysis, 2021
3.10 PESTEL analysis
Chapter 4 Blood and Blood Components Market, By Product
4.1 Key segment trends
4.2 Whole blood
4.2.1 Market size, by region, 2017-2028 (USD Million)
4.3 Blood components
4.3.1 Market size, by region, 2017-2028 (USD Million)
4.3.2 Red blood cells
4.3.2.1 Market size, by region, 2017-2028 (USD Million)
4.3.3 Platelets
4.3.3.1 Market size, by region, 2017-2028 (USD Million)
4.3.4 Plasma
4.3.4.1 Market size, by region, 2017-2028 (USD Million)
4.3.5 White blood cells
4.3.5.1 Market size, by region, 2017-2028 (USD Million)
Chapter 5 Blood and Blood Components Market, By Application
5.1 Key segment trend
5.2 Anaemia
5.2.1 Market size, by region, 2017-2028 (USD Million)
5.3 Trauma & Surgery
5.3.1 Market size, by region, 2017-2028 (USD Million)
5.4 Cancer treatment
5.4.1 Market size, by region, 2017-2028 (USD Million)
5.5 Bleeding disorders
5.5.1 Market size, by region, 2017-2028 (USD Million)
5.6 Others
5.6.1 Market size, by region, 2017-2028 (USD Million)
Chapter 6 Blood and Blood Components Market, By End-use
6.1 Key segment trend
6.2 Hospitals
6.2.1 Market size, by region, 2017-2028 (USD Million)
6.3 Ambulatory surgical centres
6.3.1 Market size, by region, 2017-2028 (USD Million)
6.4 Others
6.4.1 Market size, by region, 2017-2028 (USD Million)
Chapter 7 Blood and Blood Components Market, By Region
7.1 Key regional trends
7.2 North America
7.2.1 Market size, by country, 2017-2028 (USD Million)
7.2.2 Market size, by product, 2017-2028 (USD Million)
7.2.2.1 Market size, by blood components, 2017-2028 (USD Million)
7.2.3 Market size, by application, 2017-2028 (USD Million)
7.2.4 Market size, by end-use, 2017-2028 (USD Million)
7.2.5 U.S.
7.2.5.1 Market size, by product, 2017-2028 (USD Million)
7.2.5.1.1 Market size, by blood components, 2017-2028 (USD Million)
7.2.5.2 Market size, by application, 2017-2028 (USD Million)
7.2.5.3 Market size, by end-use, 2017-2028 (USD Million)
7.2.6 Canada
7.2.6.1 Market size, by product, 2017-2028 (USD Million)
7.2.6.1.1 Market size, by blood components, 2017-2028 (USD Million)
7.2.6.2 Market size, by application, 2017-2028 (USD Million)
7.2.6.3 Market size, by end-use, 2017-2028 (USD Million)
7.3 Europe
7.3.1 Market size, by country, 2017-2028 (USD Million)
7.3.2 Market size, by product, 2017-2028 (USD Million)
7.3.2.1 Market size, by blood components, 2017-2028 (USD Million)
7.3.3 Market size, by application, 2017-2028 (USD Million)
7.3.4 Market size, by end-use, 2017-2028 (USD Million)
7.3.5 Germany
7.3.5.1 Market size, by product, 2017-2028 (USD Million)
7.3.5.1.1 Market size, by blood components, 2017-2028 (USD Million)
7.3.5.2 Market size, by application, 2017-2028 (USD Million)
7.3.5.3 Market size, by end-use, 2017-2028 (USD Million)
7.3.6 UK
7.3.6.1 Market size, by product, 2017-2028 (USD Million)
7.3.6.1.1 Market size, by blood components, 2017-2028 (USD Million)
7.3.6.2 Market size, by application, 2017-2028 (USD Million)
7.3.6.3 Market size, by end-use, 2017-2028 (USD Million)
7.3.7 France
7.3.7.1 Market size, by product, 2017-2028 (USD Million)
7.3.7.1.1 Market size, by blood components, 2017-2028 (USD Million)
7.3.7.2 Market size, by application, 2017-2028 (USD Million)
7.3.7.3 Market size, by end-use, 2017-2028 (USD Million)
7.3.8 Spain
7.3.8.1 Market size, by product, 2017-2028 (USD Million)
7.3.8.1.1 Market size, by blood components, 2017-2028 (USD Million)
7.3.8.2 Market size, by application, 2017-2028 (USD Million)
7.3.8.3 Market size, by end-use, 2017-2028 (USD Million)
7.3.9 Italy
7.3.9.1 Market size, by product, 2017-2028 (USD Million)
7.3.9.1.1 Market size, by blood components, 2017-2028 (USD Million)
7.3.9.2 Market size, by application, 2017-2028 (USD Million)
7.3.9.3 Market size, by end-use, 2017-2028 (USD Million)
7.3.10 Russia
7.3.10.1 Market size, by product, 2017-2028 (USD Million)
7.3.10.1.1 Market size, by blood components, 2017-2028 (USD Million)
7.3.10.2 Market size, by application, 2017-2028 (USD Million)
7.3.10.3 Market size, by end-use, 2017-2028 (USD Million)
7.4 Asia Pacific
7.4.1 Market size, by country, 2017-2028 (USD Million)
7.4.2 Market size, by product, 2017-2028 (USD Million)
7.4.2.1 Market size, by blood components, 2017-2028 (USD Million)
7.4.3 Market size, by application, 2017-2028 (USD Million)
7.4.4 Market size, by end-use, 2017-2028 (USD Million)
7.4.5 Japan
7.4.5.1 Market size, by product, 2017-2028 (USD Million)
7.4.5.1.1 Market size, by blood components, 2017-2028 (USD Million)
7.4.5.2 Market size, by application, 2017-2028 (USD Million)
7.4.5.3 Market size, by end-use, 2017-2028 (USD Million)
7.4.6 China
7.4.6.1 Market size, by product, 2017-2028 (USD Million)
7.4.6.1.1 Market size, by blood components, 2017-2028 (USD Million)
7.4.6.2 Market size, by application, 2017-2028 (USD Million)
7.4.6.3 Market size, by end-use, 2017-2028 (USD Million)
7.4.7 India
7.4.7.1 Market size, by product, 2017-2028 (USD Million)
7.4.7.1.1 Market size, by blood components, 2017-2028 (USD Million)
7.4.7.2 Market size, by application, 2017-2028 (USD Million)
7.4.7.3 Market size, by end-use, 2017-2028 (USD Million)
7.4.8 Australia
7.4.8.1 Market size, by product, 2017-2028 (USD Million)
7.4.8.1.1 Market size, by blood components, 2017-2028 (USD Million)
7.4.8.2 Market size, by application, 2017-2028 (USD Million)
7.4.8.3 Market size, by end-use, 2017-2028 (USD Million)
7.5 Latin America
7.5.1 Market size, by country, 2017-2028 (USD Million)
7.5.2 Market size, by product, 2017-2028 (USD Million)
7.5.2.1 Market size, by blood components, 2017-2028 (USD Million)
7.5.3 Market size, by application, 2017-2028 (USD Million)
7.5.4 Market size, by end-use, 2017-2028 (USD Million)
7.5.5 Brazil
7.5.5.1 Market size, by product, 2017-2028 (USD Million)
7.5.5.1.1 Market size, by blood components, 2017-2028 (USD Million)
7.5.5.2 Market size, by application, 2017-2028 (USD Million)
7.5.5.3 Market size, by end-use, 2017-2028 (USD Million)
7.5.6 Mexico
7.5.6.1 Market size, by product, 2017-2028 (USD Million)
7.5.6.1.1 Market size, by blood components, 2017-2028 (USD Million)
7.5.6.2 Market size, by application, 2017-2028 (USD Million)
7.5.6.3 Market size, by end-use, 2017-2028 (USD Million)
7.5.7 Argentina
7.5.7.1 Market size, by product, 2017-2028 (USD Million)
7.5.7.1.1 Market size, by blood components, 2017-2028 (USD Million)
7.5.7.2 Market size, by application, 2017-2028 (USD Million)
7.5.7.3 Market size, by end-use, 2017-2028 (USD Million)
7.6 Middle East and Africa
7.6.1 Market size, by country, 2017-2028 (USD Million)
7.6.2 Market size, by product, 2017-2028 (USD Million)
7.6.2.1 Market size, by blood components, 2017-2028 (USD Million)
7.6.3 Market size, by application, 2017-2028 (USD Million)
7.6.4 Market size, by end-use, 2017-2028 (USD Million)
7.6.5 South Africa
7.6.5.1 Market size, by product, 2017-2028 (USD Million)
7.6.5.1.1 Market size, by blood components, 2017-2028 (USD Million)
7.6.5.2 Market size, by application, 2017-2028 (USD Million)
7.6.5.3 Market size, by end-use, 2017-2028 (USD Million)
7.6.6 Saudi Arabia
7.6.6.1 Market size, by product, 2017-2028 (USD Million)
7.6.6.1.1 Market size, by blood components, 2017-2028 (USD Million)
7.6.6.2 Market size, by application, 2017-2028 (USD Million)
7.6.6.3 Market size, by end-use, 2017-2028 (USD Million)
7.6.7 UAE
7.6.7.1 Market size, by product, 2017-2028 (USD Million)
7.6.7.1.1 Market size, by blood components, 2017-2028 (USD Million)
7.6.7.2 Market size, by application, 2017-2028 (USD Million)
7.6.7.3 Market size, by end-use, 2017-2028 (USD Million)
Chapter 8 Company Profiles
8.1 Competitive dashboard, 2021
8.2 American Red Cross
8.2.1 Business overview
8.2.2 Financial data
8.2.3 Product landscape
8.2.4 Strategic outlook
8.2.5 SWOT analysis
8.3 American Association of Blood Banks
8.3.1 Business overview
8.3.2 Financial data
8.3.3 Product landscape
8.3.4 Strategic outlook
8.3.5 SWOT analysis
8.4 Association for the Advancement of Blood & Biotherapies
8.4.1 Business overview
8.4.2 Financial data
8.4.3 Product landscape
8.4.4 Strategic outlook
8.4.5 SWOT analysis
8.5 The Associazione Volontari Italiani del Sangue (AVIS)
8.5.1 Business overview
8.5.2 Financial data
8.5.3 Product landscape
8.5.4 Strategic outlook
8.5.5 SWOT analysis
8.6 Australian Red Cross
8.6.1 Business overview
8.6.2 Financial data
8.6.3 Product landscape
8.6.4 Strategic outlook
8.6.5 SWOT analysis
8.7 Indian Red Cross
8.7.1 Business overview
8.7.2 Financial data
8.7.3 Product landscape
8.7.4 Strategic outlook
8.7.5 SWOT analysis
8.8 Carter BloodCare
8.8.1 Business overview
8.8.2 Financial data
8.8.3 Product landscape
8.8.4 Strategic outlook
8.8.5 SWOT analysis
8.9 OneBlood
8.9.1 Business overview
8.9.2 Financial data
8.9.3 Product landscape
8.9.4 Strategic outlook
8.9.5 SWOT analysis
8.10 National Blood Authority Australia
8.10.1 Business overview
8.10.2 Financial data
8.10.3 Product landscape
8.10.4 Strategic outlook
8.10.5 SWOT analysis
8.11 Versiti
8.11.1 Business overview
8.11.2 Financial data
8.11.3 Product landscape
8.11.4 Strategic outlook
8.11.5 SWOT analysis
8.12 South African National Blood Service
8.12.1 Business overview
8.12.2 Financial data
8.12.3 Product landscape
8.12.4 Strategic outlook
8.12.5 SWOT analysis
8.13 Vitalant
8.13.1 Business overview
8.13.2 Financial data
8.13.3 Product landscape
8.13.4 Strategic outlook
8.13.5 SWOT analysis
